PBYI FY 2021 Earnings — Puma Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

PBYIPuma Biotechnology, Inc.

$311M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$253M+12.5% YoY

Gross Profit

$189M74.8% margin

Operating Income

$1M0.5% margin

Net Income

-$29M-11.5% margin

EPS (Diluted)

$-0.72

Cash Flow

Operating Cash Flow

$21M

Free Cash Flow

$21M

Stock-Based Comp.

$33M

Balance Sheet

Total Assets

$227M

Total Liabilities

$229M

Stockholders' Equity

-$2M

Cash & Equivalents

$63M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$253M	$225M	+12.5%
Gross Profit	$189M	$186M	+2.0%
Operating Income	$1M	-$30M	+104.2%
Net Income	-$29M	-$60M	+51.5%